Description générale
Zoledronic acid is a bisphosphonate which reduces bone resorption through inhibition of osteoclast activity.
INN
Zoledronic acid
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2017
(TRS
1006)
pour
Malignant neoplasm metastasis in bone or bone marrow
Demande refusée en 2023
(TRS
1049)
pour
Osteogenesis imperfecta
Wikipédia
DrugBank
Recommandations
Section
Supportive medicines
- Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Section
Medicines for endocrine disorders
- Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Indications